TipRanks
Go Ultimate55% OFF

Travere Therapeutics (17R) Balance Sheet

Travere Therapeutics Balance Sheet

Travere Therapeutics's total assets for Q2 2026 were $799.36M, an increase of 43.98% from the previous quarter. CH:17R total liabilities were $774.84M for the fiscal quarter, a 69.75% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 605.19M$ 594.13M$ 788.91M$ 672.59M$ 776.63M
$ 490.36M$ 535.05M$ 588.10M$ 629.73M$ 474.52M
$ 114.83M$ 59.08M$ 200.81M$ 42.85M$ 302.11M

Currency in USD

Travere Therapeutics Debt to Assets

0300M600M900M40 %60 %80 %100 %LiabilitiesDebt to Assets201720182019202020212022202320242025AssetsLiabilitiesDebt to Assets